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PURPOSE. AGBL5, encoding ATP/GTP binding protein-like 5, was previously proposed as an
autosomal recessive retinitis pigmentosa (arRP) candidate gene based on the identification of
missense variants in two families. In this study, we performed next-generation sequencing to
reveal additional RP cases with AGBL5 variants, including protein-truncating variants.
METHODS. Whole-genome sequencing (WGS) or whole-exome sequencing (WES) was
performed in three probands. Subsequent Sanger sequencing and segregation analysis were
performed in the selected candidate genes. The medical history of individuals carrying AGBL5
variants was reviewed and additional ophthalmic examinations were performed, including
fundus photography, fundus autofluorescence imaging, and optical coherence tomography.
RESULTS. AGBL5 variants were identified in three unrelated arRP families, comprising
homozygous variants in family 1 (c.1775G>A:p.(Trp592*)) and family 2 (complex allele:
c.[323C>G; 2659T>C]; p.[(Pro108Arg; *887Argext*1)]), and compound heterozygous
variants (c.752T>G:p.(Val251Gly) and c.1504dupG:p.(Ala502Glyfs*15)) in family 3. All
affected individuals displayed typical RP phenotypes.
CONCLUSIONS. Our study convincingly shows that variants in AGBL5 are associated with arRP.
The identification of AGBL5 and TTLL5, a previously described RP-associated gene encoding
the tubulin tyrosine ligase-like family, member 5 protein, highlights the importance of poly-
and deglutamylation in retinal homeostasis. Further studies are required to investigate the
underlying disease mechanism associated with AGBL5 variants.
Keywords: retinitis pigmentosa, whole exome sequencing, AGBL5, post-translational
modification
Retinitis pigmentosa (RP) (Mendelian Inheritance in Man[MIM]268000) encompasses a clinically and genetically
heterogeneous group of inherited retinal dystrophies (IRDs)
with a worldwide prevalence of approximately 1 in 4000
individuals. Retinitis pigmentosa is characterized by initial rod
photoreceptor degeneration resulting in night blindness,
followed by midperipheral visual field loss and deterioration
of central vision due to cone photoreceptor degeneration.1 The
clinical presentation of RP is highly variable in terms of onset,
disease progression, fundus appearance, and associated ocular
features. The ophthalmic features indicative for RP include
bone spicule pigmentations with atrophy of the retinal pigment
epithelium (RPE), waxy disc pallor, and retinal arteriole
attenuation.2,3
To date, 82 genes have been implicated in RP (https://sph.
uth.edu/retnet; in the public domain). These genes encode
proteins involved in different retinal pathways, including the
phototransduction cascade, the retinoid cycle, ciliary transport,
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retinal development, and RNA splicing factors.4 Recent whole-
exome sequencing (WES) studies demonstrated that approxi-
mately 60% of RP cases can be explained by variants in these
genes (Haer-Wigman L, personal communication, 2016),5–8
suggesting that several genes are yet to be identified. This study
aimed to identify novel genes associated with RP using next-
generation sequencing (NGS) technology.
Here, we describe the identification of biallelic variants in
AGBL5 in four autosomal recessive retinitis pigmentosa (arRP)
patients from three unrelated families.
SUBJECTS AND METHODS
Subjects and Clinical Evaluation
The study protocol adhered to the tenets of the Declaration of
Helsinki and received approval from the respective local ethics
committees. Written informed consent was obtained from all
participants or parents of children prior to their inclusion in
this study. Patients were ascertained from the inherited retinal
disease clinics at the Rotterdam Eye Hospital (The Nether-
lands) and Moorfields Eye Hospital (London, UK).
Each patient underwent a full clinical examination includ-
ing visual acuity and dilated fundus examination. Retinal
fundus imaging was obtained by 358 color fundus photography
(Topcon Great Britain Ltd, Berkshire, UK), 558 fundus
autofluorescence (FAF) imaging (Spectralis; Heidelberg Engi-
neering Ltd, Heidelberg, Germany), and Spectralis optical
coherence tomography (OCT).
Full-field and pattern electroretinography (ERG, PERG)
were available from three patients, performed with gold foil
electrodes, which incorporated the International Society for
Clinical Electrophysiology of Vision (ISCEV) standards.9,10 We
also studied all retrospective data including Stratus (Carl Zeiss
Meditec, Dublin, CA, USA) OCTs.
Genetic Analysis
Genomic DNA was isolated from peripheral blood lymphocytes
according to standard salting-out procedures.11 In one
unaffected individual from family 1, DNA was extracted from
saliva material using the Oragene system (OG-500; Genotek,
Ottawa, ON, Canada).
Whole-exome sequencing of the proband from family 1 was
performed using Agilent’s SureSelect All Human Exome version
2 kit (50 Mb; Agilent Technologies, Santa Clara, CA, USA),
followed by sequencing on a SOLiD4 sequencing platform (Life
Technologies, Carlsbad, CA, USA). Reads were mapped against
the University of California, Santa Cruz (UCSC) genome
browser, human Hg19 assembly (build 37) using Lifescope
v2.1 software (Life Technologies), and variants were called
using the Genome Analysis Toolkit (GATK) v2 according to the
recommended guidelines (https://software.broadinstitute.org/
gatk/best-practices/; in the public domain). Identified variants
were filtered based on minor allele frequency < 0.005 in our
internal cohort, and the Exome Aggregation Consortium
(ExAC) database.
The proband from family 2 underwent WES analysis using
Agilent’s SureSelectXT Human All Exon version 5 exon capture
(Agilent Technologies, Santa Clara, CA, USA), followed by
sequencing on a HiSeq 2000 platform (Illumina, Inc., San
Diego, CA, USA) at AROS Applied Biotechnology (Aarhus,
Denmark). Raw fastq files were aligned to the GRCh37
reference genome using NovoAlign version 2.08.03 (Novocraft
Technologies Sdn Bhd, Petaling Jaya, Selangor, Malaysia).
Duplicate reads were marked using Picard tools MarkDupli-
cates (http://broadinstitute.github.io/picard; in the public
domain). Calling was performed using the haplotype caller
module of GATK (https://www.broadinstitute.org/gatk, ver-
sion 3.3-0; in the public domain), creating gVCF formatted files
for each sample. The individual gVCF files for the exomes
discussed in this study, in combination with ~3000 clinical
exomes (UCL-exomes consortium, University College London,
London, UK), were combined into merged VCF files for each
chromosome, on average containing 100 samples each. The
final variant calling was performed using the GATK Genotype
gVCFs module jointly for all samples (cases and controls).
Variant quality scores were then recalibrated according to
GATK best practices separately for indels and single nucleotide
polymorphisms (SNPs). Resulting variants were annotated
using ANNOVAR (http://annovar.openbioinformatics.org/; in
the public domain) based on Ensembl (http://www.ensembl.
org; in the public domain) gene and transcript definitions.
Candidate variants were filtered based on function (non-
synonymous, presumed loss of function or splicing, defined as
intronic sites within 5 bp of an exon–intron junction) and
minor allele frequency (<0.005 minor allele frequency in our
internal control group, as well as the National Heart, Lung, and
Blood Institute [NHLBI] exome sequencing dataset).
The patient from family 3 underwent whole-genome
sequencing (WGS) as part of a large collaborative study: DNA
from 599 unrelated patients with inherited retinal disease,
ascertained from the Inherited Eye Disease clinics at Moorfields
Eye Hospital (MEH), London, underwent WGS as part of the
National Institute for Health Research England (NIHR) Bio-
Resource–Rare Diseases project, Specialist Pathology Evaluat-
ing Exomes in Diagnostics (SPEED). Briefly, peripheral blood
mononuclear cell–derived genomic DNA was processed using
the Illumina TruSeq DNA PCR-Free Sample Preparation kit
(Illumina, Inc., San Diego, CA, USA) and sequenced using an
Illumina HiSeq 2500, generating a minimum coverage of 153
for ~95% of the genome. Reads were aligned to the genome
(GRCh37) using Isaac aligner (Illumina, Inc., Great Chester-
ford, UK). SNVs and indels were identified using Isaac variant
caller. Variant examination was performed only on the single
nucleotide variants (SNVs) and indels that met the following
criteria: passed standard quality filters, predicted to alter the
sequence of a protein, and had an allele frequency < 0.01 in
the 1000 genomes database, the NHLBI GO Exome Sequencing
Project (http://evs.gs.washington.edu/EVS/ release 20130513;
in the public domain), the UK10K database (http://www.
uk10k.org; in the public domain), the ExAC database (http://
exac.broadinstitute.org; in the public domain), and allele
frequency < 0.02 in ~6000 internal control genomes.
Sanger Sequencing
Primers for amplification of coding exons and flanking exon–
intron boundaries of AGBL5 (NM_021831.5) were designed
with Primer3 plus (http://www.bioinformatics.nl/cgi-bin/
primer3plus/primer3plus.cgi; in the public domain). Primer
sequences and PCR conditions are available upon request.
Pathogenicity Interpretation of Missense Variant
The Combined Annotation Dependent Depletion (CADD)
(http://cadd.gs.washington.edu/; in the public domain) score
was used to predict the pathogenicity of missense variants.
This scoring system incorporates several widely used in silico
tools, such as SIFT (http://sift.jcvi.org/; in the public domain),
PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/; in the
public domain), Mutation Taster (http://www.mutationtaster.
org/; in the public domain), PhyloP, and Grantham score. Minor
allele frequencies were obtained from the Exome Aggregation
Consortium (ExAC) database containing ~60,000 exomes of
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unrelated individuals, accessed March 2016. YASARA (Yet
Another Scientific Artificial Reality Application; http://www.
yasara.org/; in the public domain) Structure molecular
modeling package (Ver. 11.3.2) was used to build the three-
dimensional structure of AGBL5 (AAH07415.2). Thereafter,
two missense variants were introduced into this three-
dimensional model to assess the predicted effect of these
variants on the structure of the protein.
RESULTS
Clinical Findings
The clinical characteristics of patients (for pedigrees, see Fig.
1) are summarized in Table 1, and retinal imaging pictures are
shown in Figure 2. Patient F1-IV:3 was referred to the
Rotterdam Eye Hospital at age 32 with end-stage RP
complicated by cystoid maculopathy. Visual acuity at presen-
tation was hand movements in the right and light perception in
the left eye. He was pseudophakic (cataract extraction
performed at age 29), and retrospective data on visual acuity
and visual fields were not available. The cystoid maculopathy
was responsive to subcutaneous octreotide, but visual acuity
did not improve. Through the years the cysts disappeared and
atrophy of the macular region developed (Figs. 2A, 2B). He was
also suffering from Behcet’s disease, but did not have a history
of recurring uveitis. His older sister (F1-IV:2) was examined
only once, at the age of 43. She also presented with end-stage
RP. She was pseudophakic, and visual acuity was hand
movement and counting fingers. Her fundus examination
revealed optic disc pallor, attenuated vessels, macular atrophy,
midperipheral and peripheral RPE atrophy, and heavy bone
spicule pigmentation but no cystoid macular edema (not
shown). The DNA sample of this patient was not available.
Patients from families 2 and 3 initially developed nyctalopia,
with a range of onset from 9 to 30 years before subsequent
development of peripheral visual field loss. At last review (age
range, 24–45 years), there was mild visual acuity loss with best-
corrected visual acuity mean 0.34 logMAR (range, 0.30–0.48).
All patients developed posterior subcapsular cataract. Patient F2-
II:1 had learning difficulties but no other symptoms suggestive
of syndromic disease. There were fundus abnormalities consis-
tent with RP including attenuated vessels, macular and
midperipheral RPE mottling/atrophy, and peripheral intraretinal
pigment migration, most prominent in the proband of family 3
(Fig. 2I). Fundus autofluorescence imaging demonstrated a ring
of increased autofluorescence parafoveally in F2-II:1, focally
increased autofluorescence corresponding to macular edema in
F2-II:3, and a partial ring of reduced autofluorescence in F3-II:1
(Figs. 2D, 2G, 2J). All patients had midperipheral reduced
autofluorescence in keeping with regions of RPE atrophy and
increased pigmentation. On OCT, there was outer retinal
atrophy with variable preservation of photoreceptors most
apparent in F2-II:1 with a centrally preserved inner segment
ellipsoid band (Fig. 2D). Optical coherence tomography imaging
demonstrated intraretinal cysts of the inner nuclear layer, which
responded to topical carbonic anhydrase inhibitors (Figs. 2E,
2H, 2K). Electrophysiology demonstrated rod and cone system
dysfunction (Table 1).
Genetic Findings
Biallelic variants in AGBL5 were identified in four patients from
three families. These variants are summarized in Tables 1 and 2.
None of them have been previously reported in RP patients.
Whole-exome sequencing data analysis did not yield other
biallelic variants in the genes known to be mutated in IRD
(Retinal Information Network, https://sph.uth.edu/retnet/; in
the public domain). The proband of family 1 was homozygous
for the c.1775G>A:p.(Trp592*) nonsense variant in the AGBL5
gene (Fig. 3). The resulting transcript is expected to undergo
nonsense-mediated decay (NMD), suggesting that this variant is
a true loss-of-function allele. This variant was reported in 1/
121,398 alleles (0.0008%) in the ExAC dataset.
Two affected siblings from family 2 (GC15894) were
homozygous for the missense variant c.323C>G:p.(Pro108Arg).
All in silico tools predict this variant to be pathogenic (Table 2).
The altered proline residue is fully conserved throughout AGBL5
orthologues up to Tetraodon nigroviridis (Fig. 3A) and is
located in the core of AGBL5 (Fig. 3B). A change to arginine
introduces a larger amino acid, which may destabilize the
protein structure. Moreover, proline provides a rigid structure
important for interaction with ligands or other proteins. A
second homozygous variant, c.2659T>C:p.(*887Argext*1), was
also identified in the two affected members of this family. This
stop-loss variant is predicted to result in a single amino acid
residue extension of the protein. Two rare stop-loss variants
affecting other nucleotides of the AGBL5 stop codon,
c.2661A>G:p.(*887Trpext*1) and c.2661A>T:p.(*887Cysext*1),
were found in one and seven alleles in the ExAC dataset,
respectively.
The compound heterozygous variants c.1504dupG:p.
(Ala502fs*15) and c.752T>G:p.(Val251Gly) were identified
in a simplex RP patient of family 3. The p.(Val251Gly) variant
alters the valine residue flanking the consensus zinc-binding
residues of the M14-like peptidase domain. This valine is
conserved throughout paralogues and orthologues of AGBL5
(up to T. nigroviridis). Furthermore, it affects a highly
conserved nucleotide with a PhyloP score of 4.73. According
to Vissers et al.,12 by using PhyloP score distribution of
dbSNP and HGMD variants, this variant can be considered as
FIGURE 1. Pedigrees of families carrying AGBL5 variants. AGBL5
variants were identified in three autosomal recessive retinitis pigmen-
tosa (RP) families. Affected individuals are indicated with filled symbols
and unaffected relatives are indicated with open symbols. Genotypes
are shown below the pedigree symbols. M represents mutant allele and
‘þ’ represents wild-type alleles. Variant c.1775G>A:p.(Trp592*) oc-
curred in a homozygous state in F1; variants c.323C>G:p.(Pro108Arg)
and c.2659T>C:p.(*887Argext*1) occurred in a homozygous manner in
F2; and compound heterozygous variants c.752T>G:p.(Val251Gly) and
c.1504dupG:p.(Ala502Glyfs*15) were found in F3.
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pathogenic as it is close to the mean PhyloP score (4.7) of the
pathogenic de novo variants identified in persons with
intellectual disability. All in silico prediction tools indicate
that this variant is pathogenic (Table 2). Alteration of this
hydrophobic valine to glycine may destabilize the secondary
structure of AGBL5 in this domain (Fig. 3B). All variants
cosegregated with disease in the family members available for
testing (Fig. 1).
DISCUSSION
AGBL5 Is a Novel Gene Associated With RP
Previous studies by Patel et al.5 and Kastner et al.13 discovered
AGBL5 as a novel candidate gene associated with RP. These
studies identified homozygous missense variants (p.(Arg276Trp)
and p.(Asp295Asn)) in arRP cases from Saudi and Turkish origin.
FIGURE 2. Retinal imaging of affected individuals. Color fundus imaging (A, C, F, I) in four patients demonstrated optic disc pallor, attenuated
vessels, macular and midperipheral retinal pigment epithelium mottling/atrophy, and peripheral intraretinal pigment migration, heaviest in (A) and
(I). FAF imaging in three patients demonstrated a ring of increased autofluorescence parafoveally in F2-II:1 (D) with focal parafoveal increased
autofluorescence in F2-II:3 (G), likely representing cystoid macular edema. There was an incomplete ring of reduced autofluorescence parafoveally
for F3-II:1 (J). All patients had midperipheral reduced autofluorescence in keeping with regions of RPE atrophy and increased pigmentation. Stratus
OCT of the right eye in F1-IV:3 (B) at age 34 showed large cysts at the macula comprising several retinal layers with cysts in the inner nuclear layer of
the paramacular region (upper). In the lower scan (at 39 years), complete atrophy of retinal layers at the fovea can be observed. OCT imaging also
demonstrated loss of outer retina with partial preservation of the inner segment ellipsoid band in patient F2-II:1 (E), very limited photoreceptor
preservation for F2-II.3 (H) and F3-II.1 (K), and intraretinal cysts of the inner nuclear layer for all patients.
TABLE 2. AGBL5 Variants Identified in This Study and Their In Silico Analyses
DNA Variant Protein Variant ExAC Allele Frequency, % SIFT PolyPhen-2 Mutation Taster CADD Phred PhyloP
c.323C>G p.(Pro108Arg) 0 Deleterious Probably damaging Disease causing 24.0 5.45
c.752T>G p.(Val251Gly) 0 Deleterious Probably damaging Disease causing 27.1 4.73
c.1775G>A p.(Trp592*) 0.0008 NA NA NA NA NA
c.1504dupG p.(Ala502Glyfs*15) 0 NA NA NA NA NA
c.2659T>C p.(*887Argext*1) 0 NA NA NA NA NA
NA, not applicable.
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In our study, we identified five novel variants in AGBL5 in three
unrelated RP cases that further confirm the causality of this
gene. The novel variants consist of two missense, two protein-
truncating, and one stop-loss variant. To date, all missense
variants in AGBL5 with the exception of p.(Pro108Arg) are
located within the M14-like carboxypeptidase A domain (Fig.
3A), which highlights the importance of this protein domain for
AGBL5 function. This protein domain encodes cytosolic
carboxypeptidases (CCPs) that have been implicated to play a
role in the posttranslational modifications of tubulin. Further-
more, mutation of the active site of the carboxypeptidase
domain causes abnormal cilia development in zebrafish.14 The
protein-truncating variants, that is, p.(Trp592*) and p.(Ala502-
Glyfs*15), are expected to result in complete loss of function
due to premature translation termination and NMD.
The stop-loss p.(*887Argext*1) variant found in family 2
results in loss of the canonical termination codon, which leads
to the extension of the transcript by one codon and
consequent extension of the protein by a single amino acid
residue. This finding in addition to the presence of eight alleles
in control data (ExAC) with similar stop-loss variants may
suggest that the stop-loss variant is a bystander in the
pathogenesis of AGBL5 retinopathy, although a modifier or
indeed pathogenic effect cannot be ruled out.
The two arRP families reported by Patel et al.5 and Kastner
et al.13 display a classical RP phenotype, as do our patients.
There was some variability in visual function; our eldest patient
(age 63) still had relatively well-preserved visual acuity,
whereas one subject was blind at age 32. All patients showed
retinal cysts in the macula region at some stage of the disease,
but this occurs in 18% to 32% of RP patients.15
Interestingly, Kastner et al.13 reported intellectual disability
in an affected male and proposed a possible correlation
between sex and brain phenotype. In our study, learning
difficulties occurred in a female patient, which does not
support a correlation between sex and brain phenotypes.
Additional RP patients with AGBL5 variants need to be
identified to gain more insight into a possible association with
brain phenotypes.
FIGURE 3. Exon–intron structure of AGBL5, RP-associated variants, and three-dimensional modeling of missense variants. (A) Schematic
representation of AGBL5 variants identified in this and previous studies. Cross-species amino acid comparison showed that all missense variants
affect highly conserved residues. Variants identified in this study are colored in red, and variants in previous studies are in black. *These two variants
occurred homozygously in F2. (B) Three-dimensional protein modeling of AGBL5 missense variants. Three-dimensional structure of cytosolic
carboxypeptidase-like protein 5; ATP/GTP-binding protein-like 5. Wild-type and mutant residues are shown and colored in cyan and green,
respectively. The p.(Pro108Arg) variant, alter proline in position 108 to arginine, is located in the core of the AGBL5 protein. This alteration created
a larger amino acid, which may destabilize the protein structure. The p.(Val251Gly) missense variant changed the hydrophobic valine to glycine and
may destabilize the structure of AGBL5. †These two variants were identified from previous studies by Patel et al.5 and Kastner et al.,13 respectively.
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Pathak et al.14 demonstrated that knockdown of Agbl5 in
zebrafish leads to ciliopathy phenotypes, that is, axis curvature,
hydrocephalus, pronephric cysts, and abnormal multicilia
motility. However, in humans, variants in AGBL5 are associated
with nonsyndromic RP. These phenotypic discrepancies might
be caused by homologous genes in humans that might
compensate for the effect caused by these mutations. Alterna-
tively, as the NMD event was not functionally assessed, there is a
possibility that in the human patients, truncated proteins with
residual activity are being produced. Finally, recent studies show
that the use of morpholinos for gene knockdown in zebrafish
may lead to off-target effects, thereby explaining additional
phenotypes observed in the zebrafish studies.16
Imbalance of Poly- and Deglutamylation in
Posttranslational Modifications Is Associated With
RP
Approximately one-third of IRD-associated genes play roles in
maintaining the structure and function of photoreceptor
sensory cilium.17 Previous studies have implicated TTLL5, a
gene encoding a polyglutamylase (tubulin tyrosine ligase-like
family, member 5) in the pathogenesis of autosomal recessive
cone–rod dystrophy.18 AGBL5, also known as CCP5, is known
to function in polyglutamylation and deglutamylation of
tubulin, and perturbations in this pathway may lead to
photoreceptor cell degeneration.19 Tubulin glutamylation is
an essential posttranslational modification associated with
stable microtubules, neuronal axons, mitotic spindles, centri-
oles, and cilia.20 The tubulin tyrosine ligase-like (TTLL) and
CCP deglutamylases are required to maintain the balance of
tubulin glutamylation in ciliogenesis.21,22 Any imbalance in
poly- and deglutamylation might disrupt cilia function. Hyper-
glutamylation is known to diminish Tetrahymena cilia motility
and to induce axonemal microtubules defects.23 Ttll5 mutant
mice displayed a complete loss of retinitis pigmentosa GTPase
regulator (RPGR) glutamylation without marked changes in
tubulin glutamylation levels. The Ttll5 mutant mouse devel-
oped slow photoreceptor degeneration with early mislocaliza-
tion of cone opsins, features resembling those of Rpgr-null
mice.18 Ccp5 knockdown in zebrafish led to hyperglutamyla-
tion and reduced the disorganized cilia beat pattern. Ttll5, on
the other hand, plays a role in polyglutamylation, which is
crucial for microtubule sliding and cilia waveform regulation.15
Interestingly, a recent study demonstrates the role of TTLL5 in
RPGRORF15 glutamylation.24 The opposite function of AGBL5
(CCP5) in the deglutamylation process may also play an
important role in the balance of glutamate chains in
RPGRORF15. Posttranslational modifications are regulated by
several members of the TTLL and CCP gene families, and we
hypothesize that besides AGBL5 and TTLL5, other TTLL (TTLL1
through TTLL11) and CCP (CCP1 through CCP6) genes are
plausible candidate genes for IRD.
In conclusion, this study strengthens the role of AGBL5
variants in RP. The involvement of both AGBL5 and TTLL5 in
IRDs underlines the critical importance of glutamylation in
retinal function.
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